CASE STUDY - TALENT DIAGNOSTIC REPORTS FOR PRE-INVESTMENT

Evidence-led pre‑investment due diligence in days, not weeks.

When funding windows open, you don’t have weeks to triangulate innovation-risk. A venture capital team uses Talent Diagnostics to form an evidence-led, objective view of leadership, technical depth and innovation forecast—in days, not weeks.

Faster go or no‑go decisions with objective talent due diligence

At a glance:

Client type – Venture capital arm (enterprise software)
Primary team – Data Science / Investment Ops

Use case – Talent Diagnostics reports for pre‑investment due diligence

Output cadence ~3 reports per month (average)
Volume ~20 reports delivered since October
Time-to-insight – A few days (vs weeks internally)

The Challenge

Interviews and public-domain research for investment due diligence are useful—but biased, incomplete, and slow:

  • Founders, customers, and references naturally present the best version of the story.

  • Public signals can be noisy or lagging.

  • Deal windows are short and teams need a fast, defensible go/no‑go.

What We Did

We delivered Talent Diagnostics designed for pre-investment decisions:

  • Built an evidence-led view of team quality, capability coverage, and execution signals.

  • Surfaced insights beyond media or a company’s pitch deck by prioritising verifiable indicators over narrative.

  • Presented findings in a decision-ready format that investors can use immediately.

Why It Worked

Objectivity was the unlock.

Unlike due diligence assembled from stakeholders with “skin in the game,” Zeki Data’s approach:

  • Reduces narrative bias by relying on evidence-backed signals.

  • Helps investors form an independent opinion of the company’s innovation reality.

  • Produces clarity fast—so teams can act within funding-round timelines.

Results

  • Dramatically accelerated diligence: insights delivered in days instead of the weeks needed to source, verify, and analyse comparable evidence.

  • Increased throughput: steady cadence of ~3 reports/month.

  • Scaled adoption: ~20 diagnostics reports delivered since October.

Investor takeaways

  • Best for: go/no-go investment decisions

  • Key advantage: objective, evidence-led insights beyond media and pitch decks

  • Value: faster decisions, reduced bias and repeatable, reliable due diligence output

Need decision-ready Investment Due diligence for an active round?